Federal contract award
W911SR24C0011
THIS CONTRACT RESULTS FROM A BROAD AGENCY ANNOUNCEMENT WITH THE OVERALL OBJECTIVE TO DEVELOP AND STANDARDIZE AN ASSAY FOR EVALUATING IMMUNOMODULATORY ACTIVITIES OF BIOLOGICAL COMPOUNDS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ13 — GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $391.5K |
| Current contract value | $1.0M |
| Potential contract value / ceiling | $1.0M |
| Start date | Feb 1, 2024 |
| Current end date | Feb 28, 2025 |
| Potential end date | Feb 28, 2025 |
| Latest award activity | Jun 23, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 23, 2025 | P00004 | $-12.8K | THE OBJECTIVE OF THIS EFFORT IS TO DEVELOP AND STANDARDIZE AN ASSAY FOR EVALUATING IMMUNOMODULATORY ACTIVITIES OF BIOLOGICAL COMPOUNDS. |
| May 7, 2025 | P00003 | $0 | THE OBJECTIVE OF THIS EFFORT IS TO DEVELOP AND STANDARDIZE AN ASSAY FOR EVALUATING IMMUNOMODULATORY ACTIVITIES OF BIOLOGICAL COMPOUNDS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.